CN Patent
CN104622827A — 托法替布片剂及其制备方法
Assigned to Chongqing Huapont Pharm Co Ltd · Expires 2015-05-20 · 11y expired
What this patent protects
本发明属于药物制剂领域,具体涉及一种托法替布片剂及其制备方法。所述片剂选用了流动性、压缩成形性好的直压乳糖和微晶纤维素作为稀释剂和干粘合剂,并采用工艺简单的粉末直接压片法制备,工艺简单,省时节能,制备得到的托法替布片组合物质量可控,并确保了产品的稳定性。
USPTO Abstract
本发明属于药物制剂领域,具体涉及一种托法替布片剂及其制备方法。所述片剂选用了流动性、压缩成形性好的直压乳糖和微晶纤维素作为稀释剂和干粘合剂,并采用工艺简单的粉末直接压片法制备,工艺简单,省时节能,制备得到的托法替布片组合物质量可控,并确保了产品的稳定性。
Drugs covered by this patent
- Xeljanz (Tofacitinib Citrate) · Pfizer
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.